Filter
137
Text search:
biontech
Featured
Recommendations
27
Language
Document type
Guidelines
50
Fact sheets
30
Studies & Reports
24
Manuals
10
Strategic & Response Plan
5
Training Material
4
Resource Platforms
4
Infographics
4
Online Courses
3
Situation Updates
2
Brochures
1
Countries / Regions
Germany
9
Brazil
9
Russia
8
Argentina
7
Ukraine
6
Middle East and North Africa
5
South Africa
4
Mozambique
4
Latin America and the Carribbean
4
Paraguay
4
China
3
Ecuador
3
Chile
3
Colombia
2
Angola
2
Global
2
Nigeria
1
Senegal
1
Guinea-Bissau
1
Philippines
1
Somalia
1
South Sudan
1
Syria
1
Sudan
1
Peru
1
Yemen
1
East and Southern Africa
1
West and Central Africa
1
South–East Asia Region
1
Africa
1
Kazakhstan
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
61
Key Resources
3
Annual Report MEDBOX
1
Clinical Guidelines
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
117
Refugee
9
TB
2
Health Financing Toolbox
2
Ebola
1
Conflict
1
(Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та Spikevax® виробництва Moderna);
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
–
...
– (Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key information about COVID-19 vaccines through short instructional videos, vaccine explainers, job aids, topic br
...
Seit August 2021 empfiehlt die Ständige Impfkommission (STIKO) allen Kindern und Jugendlichen ab 12 Jahren die Corona-Schutzimpfung mit Comirnaty® von BioNTech/Pfizer. Seit Mitte Dezember können auch Kinder zwischen 5 und 11 Jahren mit dem darauf
...
La evidencia disponible a nivel internacional sobre el uso de un segundo refuerzo muestra una mayor duración de la respuesta inmune y una disminución de la internación y la mortalidad por COVID 19 en la población de adultos mayores y huéspedes inmunocomprometidos. Por otra parte, el personal de
...
Weekly epidemiological update on COVID-19, 28 September 2022
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a par
...
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
24 May 2021; Guidance for vaccinators on how to store, prepare, draw up and administer COVID-19 vaccines Updated May 2021 · Western Cape Edition
Practical Approach to Care Kit: Vaccine
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
En Paraguay, la vacunación contra COVID-19 inició el 22 de febrero de 2021. Se han autorizado un total de siete vacunas: Bharat-Covaxin, Moderna, Pfizer-BioNTech, AstraZeneca, Sinopharm, Sputnik V- Gamaleya y CoronaVac-Sinovac. Los grupos priorita
...
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
Stand 21. Dezember 2021
Der Verein Medizin Hilft e.V. aus Berlin hat eine Informationsbroschüre zum Thema Corona-Impfung in mehreren Sprachen erstellt
Deutsch, Englisch, Französisch, Serbisch, Türkisch, Arabisch, Farsi, Vietnamese
ІНФОРМАЦІЙНИЙ ЛИСТ Для вакцинації проти COVID-19 (коронавірусне захворювання 2019 р.) (Первинна вакцинація)
recommended
– з вакциною на білковій основі
(Nuvaxovid® виробництва Novavax)
Станом на: 15 лютого 2022 р. (даний інформаційний лист постійно оновлюється)
AUFKLÄRUNGSMERKBLATT
Zur Schutzimpfung gegen COVID-19 (Cor
...
These are standing orders for eligible nurses and healthcare professionals to administer the Moderna COVID-19 vaccine to persons 18 years of age and older
COVID-19 Situation Update OPS/WHO Argentina: 10 February 2022
Situation report generated by the OPS/WHO representation in Argentina
Campaña Nacional de Vacunación contra la COVID-19
Here are resources to help accredited continuing education (CE) providers develop and deliver education about the COVID-19 vaccines. If you have any questions about accreditation requirements or any aspect of accredited education related to these vaccines
